New hope for Muscle-Weakening disease: experimental drug enters Mid-Stage testing
Disease control
Ongoing
This study is testing an experimental drug called DNTH103 for adults with generalized myasthenia gravis, a condition that causes muscle weakness. The trial will enroll 65 participants to compare the drug against a placebo over 13 weeks, measuring safety and whether it improves da…
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC